Table 3.
MERS-CoV Epidemiology distribution based on medical conditions and Age Group.
| Medical conditions |
Comorbid |
No comorbid |
Unknown |
Symptomatic |
Asymptomatic |
Unknown |
||
|---|---|---|---|---|---|---|---|---|
| 70.56 | 21.97 | 7.47 | 90.58 | 6.71 | 2.71 | |||
| Gender | Comorbid | No comorbid | Symptomatic | Asymptomatic | ||||
| Male | 69.79 | Male | 63.05 | Male | 69.30 | Male (%) | 30.65 | |
| Female | 25.61 | Female | 33.00 | Female | 26.88 | Female | 69.35 | |
| Unknown | 4.60 | Unknown | 3.94 | Unknown | 3.82 | Unknown | – | |
| Age | Comorbid cases | No comorbid | Symptomatic | Asymptomatic | ||||
| Male (%) | Female (%) | Male (%) | Female (%) | Male (%) | Female (%) | Male (%) | Female (%) | |
| 0–19 years | 0.66 | 0.60 | 2.34 | 0.00 | 1.03 | 0.44 | 5.26 | 11.63 |
| 20–39 years | 9.23 | 7.19 | 50.00 | 79.10 | 17.76 | 25.33 | 47.37 | 16.28 |
| 40–59 years | 41.32 | 39.52 | 42.97 | 20.90 | 41.38 | 34.67 | 26.32 | 51.16 |
| 60–79 years | 36.04 | 44.91 | 4.69 | 0.00 | 30.34 | 33.33 | 15.79 | 16.28 |
| 80 & Above | 12.75 | 7.78 | 0.00 | 0.00 | 9.48 | 6.22 | 5.26 | 4.65 |